相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease
Hyunjin Kim et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Blood neurofilament light: a critical review of its application to neurologic disease
Christian Barro et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Neuromyelitis optica spectrum disorders: still evolving and broadening
Kazuo Fujihara
CURRENT OPINION IN NEUROLOGY (2019)
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
Mitsuru Watanabe et al.
NEUROLOGY (2019)
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Christian Barro et al.
BRAIN (2018)
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
S. Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil et al.
NATURE REVIEWS NEUROLOGY (2018)
Serum GFAP as a biomarker for disease severity in multiple sclerosis
A. Abdelhak et al.
SCIENTIFIC REPORTS (2018)
Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6
Yuzhen Wei et al.
NEUROIMMUNOMODULATION (2018)
What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients
Shahd H. M. Hamid et al.
JOURNAL OF NEUROLOGY (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
Jens Kuhle et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury
Linda Papa et al.
JAMA NEUROLOGY (2016)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody
Kensuke Ikeda et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Neuromyelitis optica: clinical features, immunopathogenesis and treatment
S. Jarius et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks
Akiyuki Uzawa et al.
CLINICA CHIMICA ACTA (2013)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Simone Mader et al.
JOURNAL OF NEUROINFLAMMATION (2011)
GFAP in health and disease
J. Middeldorp et al.
PROGRESS IN NEUROBIOLOGY (2011)
Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells
Makoto Kinoshita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Astrocytic damage is far more severe than demyelination in NMO A clinical CSF biomarker study
R. Takano et al.
NEUROLOGY (2010)
Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker
T. Misu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Statistics in medicine - Reporting of subgroup analyses in clinical trials
Rui Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
分享论文
